DURHAM, N.C. — Researchers at the Duke Cancer Institute who have been studying prostate cancer cells for decades now think they know why PSA (prostate-specific antigen) levels reflect cancer progression.“This is the first demonstration of a mechanism that explains why PSA is a bad thing for a tumor to produce,” said senior author Sal Pizzo, M.D., Ph.D., chair of the Duke Department of Pathology. “I am willing to bet there is also a connection in cancerous cell growth with this particular biological signaling mechanism happening in other types of cells.”
To read the full, original article click on this link: Researchers learn why PSA levels reflect prostate cancer progression | Science Blog
